Sorrento Therapeutics Inc...

AI Score

0

Unlock

0.00
-0.00 (-100.00%)
At close: Mar 03, 2025, 3:53 PM
0.00
-57.14%
Pre-market: Jan 02, 2025, 09:30 AM EST

Sorrento Therapeutics Ratios Statement

Year FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
PE Ratio -0.01 -0.03 -0.05 -0.01 -0.01 0.29 -0.04 -0.07 -0.08 -0.06 -0.2 -0.26 -0.42 -0.56 -0.17 -0.08 -0.01 -0.01 -3.21 -3.21
PEG Ratio 0.00 -0.00 0.00 -0.00 0.00 -0.00 0.02 0.02 0.01 -0.00 -0.01 -0.00 -0.01 0.01 0.00 0.00 -0.00 -0.00 n/a n/a
PS Ratio 0.06 0.26 0.39 0.15 0.12 0.02 0.30 0.70 0.70 2.65 1.68 1.62 1.12 96.88 n/a n/a n/a n/a n/a n/a
PB Ratio -0.2 0.17 0.09 0.06 0.01 0.01 0.03 0.02 0.02 0.02 0.16 0.20 0.15 0.16 0.08 1.20 -0.01 -0.08 -0.01 -0.01
P/FCF Ratio -0.01 -0.05 -0.08 -0.03 -0.02 -0.02 -0.03 -0.07 -0.09 -0.07 -0.23 -0.23 -0.48 -0.67 -0.16 -0.03 n/a 0.26 n/a n/a
P/OCF Ratio -0.01 -0.05 -0.1 -0.03 -0.02 -0.03 -0.03 -0.08 -0.09 -0.07 -0.26 -0.31 -0.49 -0.71 -0.16 -0.03 n/a 0.26 n/a n/a
OCF/S Ratio -4.68 -5.33 -3.99 -5.5 -5.27 -0.65 -8.7 -9.17 -7.52 -35.84 -6.51 -5.18 -2.27 -135.78 n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -7.23 3.02 1.03 3.70 1.11 0.03 0.59 0.06 0.11 0.07 n/a n/a n/a n/a n/a n/a n/a n/a -0.03 -0.03
Quick Ratio 0.26 1.18 0.87 0.56 2.91 0.38 1.18 4.57 7.73 5.96 8.99 9.90 9.20 9.79 169.18 6.66 n/a n/a n/a n/a
Current Ratio 0.29 1.24 0.89 0.59 2.91 0.38 1.18 4.57 7.73 5.96 8.99 9.90 9.20 9.79 169.18 6.66 n/a n/a n/a n/a
Asset Turnover 0.13 0.08 0.07 0.06 0.03 0.32 0.02 0.01 0.03 0.00 0.09 0.12 0.12 0.00 n/a n/a n/a n/a n/a n/a
Interest Coverage -58.82 -36 -9.99 -5.4 -2.25 10.51 -37.2 -44.8 -21.33 -85.58 -664.74 -544.86 -478.65 -80.47 -118.11 n/a n/a n/a n/a -1
Return on Equity (ROE) 30.79 -5.45 -1.87 -4.57 -0.97 0.05 -0.76 -0.32 -0.32 -0.33 -0.78 -0.77 -0.36 -0.29 -0.48 -14.55 0.93 9.48 0.00 0.00
Return on Assets (ROA) -1.21 -0.62 -0.58 -0.64 -0.3 0.02 -0.15 -0.13 -0.24 -0.24 -0.71 -0.71 -0.32 -0.27 -0.48 -12.37 n/a n/a n/a n/a
Return on Capital (ROIC) -3.48 -0.66 -0.46 -0.44 -0.21 0.13 -0.18 -0.24 -0.26 -0.25 -0.78 -0.77 -0.36 -0.3 -0.49 -12.94 0.93 9.48 0.00 0.00
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 46.77% 75.37% 75.14% 61.07% 52.49% 92.74% 54.66% 57.52% 46.59% 99.04% 100.00% 100.00% 100.00% 100.00% n/a n/a n/a n/a n/a n/a
Net Profit Margin -911.6% -810.93% -771.69% -1.14K% -960.41% 5.97% -747.34% -998.06% -906.07% -4.76K% -830% -611.6% -264.94% -17.41K% n/a n/a n/a n/a n/a n/a
Pretax Profit Margin -893.95% -874.28% -776.72% -1.14K% -1.01K% 10.09% -795.3% -299.78% -950.56% -4.76K% -830% -611.6% -264.94% -17.41K% n/a n/a n/a n/a n/a n/a
Operating Profit Margin -802.55% -695.68% -503.99% -620.97% -610.94% 34.46% -734.76% -1.61K% -908.29% -4.71K% -831.25% -612.72% -265.49% -17.63K% n/a n/a n/a n/a n/a n/a
FCF Margin -489.37% -549.47% -492.96% -586.78% -627.39% -72.54% -953.78% -997.3% -767.45% -3.79K% -744.36% -717.16% -233.36% -14.42K% n/a n/a n/a n/a n/a n/a
EBITDA Margin -859.22% -824.11% -689.47% -981.15% -694.08% 18.03% -740.16% -212.16% -824.73% -4.43K% -779.75% -581.51% -261.51% -17.36K% n/a n/a n/a n/a n/a n/a